Bone metabolism is affected by mechanical, genetic, and environmental factors and plays a major role in osteoporosis. Nevertheless, the influence of environmental pollution on the occurrence of osteoporosis is still unclear and controversial. In this context, heavy metals are the most important pollutants capable to affect bone mass. The aim of this study was to investigate whether heavy metals accumulation in bone tissues could be related to the altered bone metabolism and architecture of osteoporotic patients. To this end, we analyzed 25 bone head biopsies osteoporotic patients and 25 bone head biopsies of osteoarthritic patients. Moreover we enrolled 15 patients underwent hip arthroplasty for high-energy hip fracture or osteonecrosis of the femoral head as a control group. Bone head biopsies were studied by BioQuant-osteo software, scanning electron microscopy and Energy Dispersive X-ray microanalysis. We found a prevalence of lead, cadmium and chromium accumulation in osteoporotic patients. Noteworthy, high levels of sclerostin, detected by immunohistochemistry, correlate with the accumulation of heavy metal found in the bone of osteoporotic patients, suggesting a molecular link between heavy metal accumulation and bone metabolism impairment. In conclusion, the presence of heavy metals into bone shed new light on the comprehension of the pathogenesis of osteoporosis since these elements could play a non redundant role in the development of osteoporosis at cellular/molecular and epigenetic level. Nevertheless, in vivo and in vitro studies need to better elucidate the molecular declare that they have no conflict of interest. The study is original and the manuscript has not been published yet and is not being considered for publication elsewhere in any language either integrally or partially except as an abstract. All authors have agreed with the submission in its present (and subsequent) forms.
INTRODUCTION
Osteoporosis is the most common metabolic bone disease, characterized by a decrease of bone mass and a degenerative change of bone microstructure, resulting in an increased risk of fracture (Cerocchi et al., 2013) . A rapidly expanding amount of evidence indicates that osteoporosis is likely to be caused by complex interactions between local and systemic regulators of bone cell function. Indeed, osteoporosis results in a dysfunction of physiological bone turnover where endocrine and/or autocrine/paracrine factors negatively affect peak bone mass and/or skeletal homeostasis (Drake et al., 2015 , O'Flaherty, 2000 . Patients with osteoporosis show a higher propensity to spine, femur and fractures. Osteoporotic fracture caused by a minor injury often occurs in cancellous bone-rich zone, with increasing disability and lethality rates, which may seriously affect the quality of life of older persons (Andreoli et al., 2011) .
Several studies, revealed that heavy metals exposure may affect bone mass (James and Meliker, 2013; Sadeghi et al., 2014; Tsai et al., 2015) . In particular, lead (Pb) is associated to bone mass deficiency and osteoporotic condition. Pb accumulates in bones already during fetal development, and adverse effects on bone metabolism present even after low level of exposure (Berglund et al., 2000; Khalil et al., 2008) . It causes growth retardation by inhibiting endochondral ossification. Increased bone turnover and reduced mineralization combine to decrease bone mineral density and mass, and, in the most severe cases, cause osteoporosis (Dermience et al., 2015) . Other important heavy metals that influence bone metabolism are cadmium (Cd), copper (Cu), chromium (Cr), and cobalt (Co) . In vitro studies demonstrated toxic effects of Cd and Cr on bone cells. In particular, ions form of these elements affects osteoblast proliferation, size, and shape (Bhattacharyya, 2009; Soudani et al., 2011) . Moreover, Cd and Cr are able to influence osteoblastic activity by decreasing alkaline phosphatase levels and calcium accretion (Dermience et al., 2015) . Co is an essential trace element since it is the core component of vitamin B12. Several in vitro studies revealed that Co influences bone resorption and bone formation by modulating bone cell metabolism (Dermience et al., 2015) . Moreover, Fleury et al. demonstrated that Co accumulation increases oxidative stress in bone tissues (Fleury et al., 2006) . These effects could be mediated by the redox state in osteoblast-like cells, but the mechanism of action is not known (Fleury et al., 2006) . However, studies were mainly performed in vitro or in human serum and rarely on bone by ultrastructure analysis. Therefore, the aim of this study was to investigate whether heavy metals accumulation in bone tissues, i.e. Pb, Cd, Co, and Cr, could be related to the altered bone metabolism and architecture of osteoporotic patients.
MATERIAL END METHODS

Patients
In this retrospective study, we enrolled 25 patients that underwent hip arthroplasty for medial femoral fracture (OP) (18 women and 7 men; age 77.80 6 1.94) and 25 patients underwent hip arthroplasty for osteoarthritis (15 women and 10 men; age 73.80 6 1.24) in the Orthopedic Department of "Tor Vergata" University. Moreover we enrolled 15 patients (7 women and 8 men; age 46.19 6 2.78) underwent hip arthroplasty for high-energy hip fracture of the femoral head as a control group. All patients enrolled in the study lived in the metropolitan area of Rome, Italy for at least 30 years.
Exclusion criteria were history of neoplastic diseases, myopathies or other neuromuscular diseases or chronic administration of corticosteroid for autoimmune diseases (more than 1 month), diabetes, alcohol abuse, viral chronic infections (HBV, HCV, HIV), previously orthopedic surgical implants.
Bone Mineral Density Evaluation
Bone mineral density evaluation (DXA) was performed with a Lunar DXA apparatus (GE Healthcare, Madison, WI). Lumbar spine (L1-L4) and femoral (neck and total) scans were performed, and bone mineral density (BMD) was analyzed according to manufacture recommendations (Celi et al., 2013) . Dual-energy X-ray absorptiometry measures BMD (in grams per square centimeter) with a coefficient of variation of 0.7%. For patients with cervical femoral fragility fracture, BMD was measured on the limb opposite to the fracture side. Conversely, for the other patients all measurements were performed on the nondominant side, while participants lay supine on an examination table with their limbs abducted away from the trunk (Piccirilli et al., 2014) . DXA exam was performed 1 day before surgery for OA patients and 1 month after surgery for hip fracture patients. Results were expressed as T scores values.
Radiographic Analysis
Hip radiographs of all patients were obtained using a standard, validated protocol (Kothari et al., 2004) . Two orthopedists independently, and at different time, assessed all radiographs using the Kellgren-Lawrence (K 2 L) radiographic atlas (Kellgren and Lawrence, 1957) . Disagreements between the two orthopedists were resolved by consulting a third orthopedist. If at least one hip joint was graded as K-L 2, the participant was diagnosed with radiographic hip osteoarthritis.
Hematochemical Exam
During hospitalization, we collected blood samples by both OP and OA patients.
Samples (n 5 50) were investigated for serum concentrations assay of creatinine, azotemia (BUN), phosphorus, calcium, Vit D (25OHD3) and intact PTH.
Sampling
During open surgery of hip arthroplasty, we took the femoral head to obtain a bioptic sample ( Fig. 1 ). For bioptic procedure, we excluded macroscopic alteration of trabecular bone as necrosis areas. All sampling and experiments were performed in agreement with independent ethical committee of "Policlinico Tor Vergata" (approval reference number # 85/ 12), and Informed consent was obtained from all individual participants included in the study.
Histology and Histomorphometric Analysis
Bone head samples were fixed in 4% paraformaldehyde for 24 h and paraffin embedded without decalcification process. From each patient, we obtained two paraffin blocks. Finally, 3-mm-thick sections were cut with tungsten carbide knife and stained with hematoxylin and eosin (H & E).
For each bioptic sample of OP and OA patients, we evaluated at least 10 microscopic images randomly selected from at least two bone slides for patient. Images were acquire at 403 magnification by using a Nikon Eclipse E600light microscope connected to a Nikon digital camera and saved at a resolution of 1280 3 1024 pixels. Successively, the images were analyzed by using a BioQuant Osteo software (version7.20.10; BIOQUANT Image Analysis Corporation, Nashville, USA) according to the manufacture's suggestions . From the BioQuant Osteo analysis we evaluated the following parameters: bone volume (BV/TV), trabecular thickness (Tb.Th) and trabecular separation (Tb.Sp). Washings were performed with PBS/Tween20 pH 7.6 (UCS diagnostic, Rome, Italy); reactions were revealed by HRP-DAB Detection Kit (UCS diagnostic, Rome, Italy).
Scanning Electron Microscopy (SEM)
One cm in diameter and 1 cm in length of bone trabecular biopsies, distant 0.2 cm to cartilage (Fig. 1) , were fixed in 4% (v/v) paraformaldehyde for 24 h. After washing with 0.1 M phosphate buffer, the sample was dehydrated by a series of incubations in 30, 50, and 70% (v/v) ethanol. Dehydration was continued by incubation steps in 95% (v/v) ethanol, absolute ethanol and acetone. Critical point drying (Agar Scientific, Essex, UK, Elektron Technology UK, Cambridge, UK) with supercritical CO 2 was then performed to prevent cell deformation (Carpentieri et al., 2015) . A SEM LEO 1450VP (Carl Zeiss Meditec, Oberkochen, Germany) was employed to acquire backscattered electron images using 20 keV electrons leading to an information depth of about 1.5 lm. Images with a scan size of 30 3 30 lm 2 were acquired, at a resolution of 1024 3 1024 pixels.
EDX Microanalysis
In recent studies, we applied EDX assay to human biopsies to study both the elemental composition of tissue and heavy metals associated to lung cancers (Scimeca et al. 2014a,b; Scimeca et al., 2016a) .
The EDX microanalysis performs the chemical analysis of a sample describing the elemental composition of a tissue utilizing electron microscopy techniques. When the electron beam in an electron microscope hits a thin sample, some atoms of the sample will be excited or ionized. When they return into their ground state, they will emit characteristic Xrays (Scimeca et al., 2016b) . The X-ray emission at different wavelengths may then be measured by a photon-energysensitive detector. EDX microanalysis was performed on unpost-fixed and uncoated bone biopsies were placed on specific stub using a liquid N2-cooled Si detector with a superultrathin Be window. Spectra were collected by a SEM LEO 1450VP scanning electron microscope at acceleration voltage of 5 KeV employing an area scan mode (640 3 640 lm 2 sampling area), 300 s acquisition time, and 32-37% detector dead time. Analysis of acquired spectra was performed under a nonstandard mode using atomic numberabsorption-florescence correction (ZAF) methods using Inca Energy software (Oxford Instruments, High Wycombe, UK; Si(Li) detector, ATW-atmospheric thin window, resolution 133 eV for Mn Ka at 10,000 counts). For each specimen, we acquire five spectrum on 8 mm 2 of bone surface in total. Results were expressed as presence or absence of metals.
Immunohistochemistry
Immunohistochemical characterization was performed to assess sclerostin expression in all femoral head biopsies.
Briefly, 3-lm-thick sections were pre-treated with EDTA citrate pH 7.8 for 30 min at 958C and then incubated with mouse monoclonal Anti-sclerostin antibody for 60 min (1:100, clone MY-32, AbCam).
Statistical Analysis
Descriptive statistics was used to summarize pertinent study information. Categorical variables were reported as frequencies and percentage values, whereas continuous variables were summarized by mean values and their relative standard deviations. Correlations between categorical variables were evaluated through non-parametric tests, such as the Pearson's Chi-Square test or the Fisher exact test, when appropriate. P values < 0.05 denote statistically significant correlations. Statistical analyses were carried out using the SPSS software (SPSS ver. 21.0, SPSS, Chicago, IL). Clinical and Immunohistochemical data were analyzed by Mann-Whitney test (p < 0.0005) using Graph Pad Prism 5 Software (La Jolla, CA).
RESULTS
Histomorphometrical Analysis
The BioQuant Osteo software allowed us to analyze the bone quality parameters such as bone volume (BV/TV), trabecular thickness (Tb.Th), and trabecular separations (Tb.S) [ Fig. 2(A-C) ]. As regards to BV/TV, we observed a significantly higher mean value in OA patients respect to OP group (OA 0.251 6 0.018 vs. OP 0.113 6 0.008 mm 2 ) [ Fig. 2(A) ]. Noteworthy, dispersive graph shows that OA group was characterized by very heterogeneous BV/TV values. Indeed, in this group we observed patients with both high value of BV/TV and levels of BV/TV compatible with OP condition. However, our data indicated that in OA group low BV/TV values were associated with older patients. Tb.Th values were significantly higher in OA respect to OP groups (OA 0.242 6 0.084 mm vs. OP 0.112 6 0.027 mm) [ Fig. 2(B) ]. In OP patients, Tb.Th values were very low and only six patients were characterized by values similar to those of OA group. Conversely, we note a homogenous distribution of Tb.Th values in OA. As concern Tb.S values OP patients showed higher values respect to OA [ Fig. 2(C) ] (OA 0.499 6 0.115 mm; OP 1.080 6 0.269 mm).
Heavy Metals Detection
In this study we set up an ultrastructural microanalysis assay in order to characterize the presence of Pb, Cr, Cd, and Co in head femoral biopsies [ Fig. 2(D-F) ]. Differences between OP and CTRL and OA groups were statistically significant in terms of Pb, Cr, and Cd accumulation in bone (Fig. 3) . Considering the individual elements, Pb was detected in 92% of OP samples, whereas Cr and Cd were present in 60% and 32%, respectively (Fig. 3) . Conversely, we did not found differences in the accumulation of Co (OP 32%; OA, 28%; CTRL 7%) ( Fig. 3) . A high rate of OP femoral head biopsies showed the co-presence of more than one bioaccumulated element (Fig. 3) . Interestingly, we could find significant differences (P < 0.0001) among the groups, when we compared the bio-accumulation of two or more elements. In particular, at least two elements were present in 80% of OP, 44% of OA, and 7% CTRL, whereas more than three elements were found in 48% of OP and 4% OA (Fig. 3) . The frequency of accumulation of toxic elements in CTRL group was less and the presence of two elements was only occasionally reported (at least two elements 7%; at least three elements 0%) (Fig. 3 ).
Immunohistochemistry
Sclerostin analysis was performed by immunohistochemistry and the levels of its expression were quantified by assigning a score from 1 to 3 according to the intensity of positive signals in osteocyte cells. As aspect, we observed a significantly higher signal of sclerostin in OP group respect to both CTRL and OA patients (OP 2.28 6 0.15; OA 1.32 6 0.13; CTRL 0.92 6 0.08) ( fig.4) . We also compared the expression of sclerostin between OP patients with at least three heavy metal elements and OP patients with less than three elements. Our data showed a significant rise of sclerostin expression in patients with at least three elements [ Fig.  4(H)] . Surprisingly, only in OP patients, sclerostin was expressed by bone marrow adipocytes too.
Clinical Evaluation
Clinical and instrumental evaluation allowed us to characterize patients enrolled in this study. OP group included 25 patients with fragility hip fracture, T score 22.5 SD and K-L score from 0 to 1; whereas OA group included 25 patients with positive radiogram for hip OA with a K-L score 3 or 4 and T score 22.5 SD. Moreover, OA and OP patients displayed homogenous values of mainly hematochemical exams of both bone and kidney metabolism (Table  I) . Finally, for CTRL patients we assume T score 22.5 SD and K-L score from 0 to 1.
DISCUSSION
The skeleton is a metabolically active organ since mechanical, genetic and environmental factors affect bone metabolisms that undergoe continuous remodeling throughout life. Nevertheless, the role of environmental pollution on bone metabolism is still unclear and controversial. Exposure to heavy metals, the most important pollutants capable to affect bone mass (Berglund et al., 2000; Sadeghi et al. 2014; Zheng et al., 2014; Tsai et al., 2015 ) continues even though several adverse health effects have been known and international associations such as the WHO (WHO, 1992 (WHO, , 1995 monitor them regularly. The main threats to human health from heavy metals are associated with Pb, Cd, Co, and Cr exposure.
To investigate the influence of Pb, Cr, Cd, and Co on a metabolic disorder of the bone disease such as osteoporosis, we analyzed 25 bone biopsies of OP patients with femur fragility fracture by SEM-EDX microanalysis to evaluate their (34). Trabeculae were thinned and bone marrows was frequently substituted by fat (asterisks) (F) Immunohistochemical reaction display high sclerostin expression by osteocyte cells (arrows) (310). (G) Graph showed a significantly higher signal of sclerostin in OP group respect to both OA and CTRL patients. (H) Graph displayed a significant rise of sclerostin expression in OP patients with at least three elements respect to OP patients with less than three elements. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] elemental composition. In addition, we enrolled OA patients to compare heavy metal accumulation in patients with similar age range. As control group, we studied bone femoral head biopsies of patients with high-energy fracture or osteonecrosis (CTRL).
Bone morphometric analysis showed a reduction of both BV/TV and Tb.Th in OP patients. Moreover, in this group, bone remodeling was often missing (data not shown). Nevertheless, evaluating the distribution of bone quality values, we noted that some OP patients showed bone quality comparable to OA group. The evaluation of bone morphology allowed us to demonstrate that cells involved in bone remodeling (osteoblasts, osteoclasts, and osteocytes) were often rare or absent in bone head trabecular tissues of OP patients.
Several studies demonstrated the epidemiological correlation between environmental pollution and occurrence of OP (Kung and Huang, 2007; Ongphiphadhanakul, 2007) . However, to the best of our knowledge, any study has been performed about heavy metals accumulation into bone tissue at the ultrastructural and microanalytical level.
Thanks to the SEM-EDX microanalysis we demonstrated a specific accumulation of heavy metals in trabecular bone tissue. Toxic elements bio-accumulation appears a time dependent phenomenon, as demonstrated by the low presence of metals in under 50 patients (CTRL). Indeed, we demonstrated that trabecular tissues of OP patients harbor a higher number heavy metals (i.e., Pb, Cr, and Cd) than patients with comparable age (OA). It should be noted that the heavy metals we detected coincide with those emitted in the atmosphere by natural and/or anthropic sources (Bell et al., 2009; Srimuruganandam and Nagendra, 2011) .
The most frequent element in bone of OP group was Pb. In vitro experiments demonstrated the ability of Pb to inhibit osteoblast differentiation and activity (Dermience et al., 2015) . In particular, it affects hormonal secretion and hormonal-induced cell responses, particularly to 1,a25-dihydroxycholecalciferol and IGF-1, inhibits bone-related protein synthesis, including osteocalcin, collagen and osteopontin, and suppresses Wnt signaling (Angle et al., 1990 , Sauk et al., 1992 . The possible inhibition of osteoblast exerted by Pb, allowed us to explain the inverse correlation between Pb accumulation and bone quality observed in our samples. Indeed, we frequently detected Pb in bone tissues of OP patients with lower values of BV/TV (data not shown). Noteworthy, the presence of Pb was observed also in 52% of OA patients and in 20% of CTRLs. For long time the negative effect of Cd on bone mass was attributed to its capability to cause renal tubular dysfunction (Schutte et al., 2008) . However, recent studies highlighted the direct role of cadmium on bone metabolisms (Yokota and Tonami, 2008) . The direct pathway implicated in cadmium bone toxicity could be linked to calcium homeostasis and bone cell metabolism. Because of similar properties, Cd can impair calcium metabolism during osteogenesis and bone homeostasis by increasing calciuria and altering calciotropic hormones (Dermience et al., 2015) . In this context, our data support the hypothesis of a direct role of Cd in bone metabolism. Indeed, as for Pb, we displayed Cd accumulation in patients with lower bone quality parameters. Moreover, tissues with both Pb and Cd accumulation were characterized by both poor bone quality and reduction/absence of osteoblasts. Cr intoxication from environmental exposure is not common, except in chromium-related industries and associated environments (Soudani et al., 2011) . Reduced bone formation may be mediated via cytotoxic effects of Cr on osteoblasts, which reduce proliferation, inhibit osteocalcin release, and decrease alkaline phosphatase activity. These effects are associated with oxidative stress, which can be caused by unbalanced OPG/RANKL ratios and dysregulation of antioxidant enzyme expression (Anderson et al., 1997) . Our data showed that the accumulation of Cr into bone structure was less frequent respect to Pb. However, in some OP samples we identified simultaneous presence of Pb, Cd, and Cr. Noteworthy, in the context of OP group we found a significantly difference between t score values of patients with at least three elements (Pb included) and t score values of patients with less than three elements. In particular, OP patients with at least three elements showed a low BMD. Moreover, these patients showed low values of main morphological parameters such as BV/TV and Tb.Th (data not shown). In the human, the inverse relationship between heavy metals (Pb and Cd) and BMD values were already described (Khalil et al., 2008; Callan et al., 2015; Rzymski et al., 2015; Garc ıa-Esquinas et al., 2015) . Nevertheless, in these studies heavy metals were found in blood but not into bone structure. Therefore, the ability of heavy metals to affect BMD could be just speculate. Indeed, the accumulation of heavy metals in the blood can indirectly influence bone metabolism affecting renal function and/or female reproductive system (Rzymski et al., 2015) .
To correlate heavy metal accumulation with bone metabolism, we studied the expression of sclerostin, a protein with anti-anabolic effects on bone formation (Yavropoulou et al., 2014) . High levels of sclerostin revealed in tissues with Pb, Cd, and Cr, candidate it as a molecular link between heavy metals accumulation and bone metabolism impairment. Indeed, sclerostin expression was higher in tissues with at least two heavy metals accumulated.
Summing up, our data highlighted the importance of Pb, Cd, and Cr in bone health. The presence of these elements is convincingly connected to the environmental pollution, as assessed by habitat conditions of the investigated patients. Indeed, they live in a large urban center in which heavy metals concentration is often upper safety threshold values. However, the possible sources of heavy metals, such as contaminated water and food, dental implant, etc., are numerous and difficult to identify.
CONCLUSION
The identification of heavy metals into bone structure opens new perspectives about the pathogenesis of osteoporosis. In addition, from clinical point of view, the detection of heavy metals contamination into the bone or other tissues (i.e., blood) could become a powerful tool to assessing bone status. To better elucidate the molecular mechanism in which heavy metals can participate to osteoporosis development in humans, in vivo and in vitro studies are needed. Furthermore, it would be interesting to validate the results of present study in a larger cohort of patients correlating SEM-EDX data with serum concentration of heavy metals. In fact, heavy metals, such as Pb, Cr, and Cd, could contribute to development of osteoporosis at both cellular/molecular and epigenetic level.
